Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Implement regular reconciliations between budgeted and actuals, plus automated alerts for variances to maintain a precise budget outlook.
13,009 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A 63-year-old faces a pivotal retirement choice: retire now or stay employed. With $480,000 saved and no pension, two...
A rising share of investors with concentrated positions are turning to tax-aware diversification as market conditions...
As Nvidia's earnings hours away approach, investors crave clarity on AI demand, profitability, and guidance. This pie...
Bitcoin pauses near the $78,000 level as ZEC and HYPE push higher, stealing the spotlight from BTC. A broad altcoin r...
As June approaches, investors weigh whether the vaneck semiconductor right head ETF belongs in their portfolios. This...
Two Vanguard bond ETFs placed in one brokerage account are delivering reliable monthly distributions, illustrating a ...
A seismic shift is brewing in the card world. Capital One's integration with Discover could turn payment processing i...
In 2022, the 3x levered ETF SOXL plunged about 90%, even as the broader semiconductor group endured a mid-cycle decli...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...
Discover FitLife's 2025 earnings story, from revenue drivers to margins and cash flow. This guide breaks down what th...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...